Alterations should be designed cautiously and the frequency of blood glucose monitoring should be elevated. Changes in concomitant oral antidiabetic procedure may be necessary. Short SAFETY Assertion: Failure to use the Dexcom Continuous Glucose Monitoring Method and its factors based on